Cambridge Investment Research Advisors buys $27,153,738 stake in Procter & Gamble Co (PG)

Procter & Gamble Co (PG) : Cambridge Investment Research Advisors scooped up 19,656 additional shares in Procter & Gamble Co during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 3, 2016. The investment management firm now holds a total of 330,619 shares of Procter & Gamble Co which is valued at $27,153,738.Procter & Gamble Co makes up approximately 0.61% of Cambridge Investment Research Advisors’s portfolio.

Other Hedge Funds, Including , Edmp boosted its stake in PG in the latest quarter, The investment management firm added 296 additional shares and now holds a total of 27,981 shares of Procter & Gamble Co which is valued at $2,298,080. Procter & Gamble Co makes up approx 2.22% of Edmp’s portfolio.Sol Capital Management Co reduced its stake in PG by selling 75 shares or 0.33% in the most recent quarter. The Hedge Fund company now holds 22,678 shares of PG which is valued at $1,862,544. Procter & Gamble Co makes up approx 0.59% of Sol Capital Management Co’s portfolio.Dupont Capital Management Corp boosted its stake in PG in the latest quarter, The investment management firm added 61,494 additional shares and now holds a total of 395,672 shares of Procter & Gamble Co which is valued at $31,701,241. Procter & Gamble Co makes up approx 0.72% of Dupont Capital Management Corp’s portfolio.Argyle Capital Management reduced its stake in PG by selling 350 shares or 1.09% in the most recent quarter. The Hedge Fund company now holds 31,663 shares of PG which is valued at $2,536,840. Procter & Gamble Co makes up approx 1.14% of Argyle Capital Management’s portfolio.

Procter & Gamble Co opened for trading at $82.15 and hit $82.6799 on the upside on Tuesday, eventually ending the session at $82.48, with a gain of 0.44% or 0.36 points. The heightened volatility saw the trading volume jump to 62,23,170 shares. Company has a market cap of $219,550 M.

On the company’s financial health, Procter & Gamble Co reported $0.86 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 26, 2016. Analyst had a consensus of $0.82. The company had revenue of $15755.00 million for the quarter, compared to analysts expectations of $15809.32 million. The company’s revenue was down -6.9 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.92 EPS.

Many Wall Street Analysts have commented on Procter & Gamble Co. Shares were Reiterated by UBS on Apr 27, 2016 to “Neutral” and Lowered the Price Target to $ 85 from a previous price target of $88 .Shares were Reiterated by B. Riley & Co. on Mar 30, 2016 to “Neutral” and Lowered the Price Target to $ 74 from a previous price target of $81 .Procter & Gamble Co was Upgraded by Sterne Agee CRT to ” Buy” on Feb 16, 2016.

The Procter & Gamble Company (P&G) provides consumer packaged goods. The Company operates in five segments under GBUs: Beauty which offers a range of products ranging from deodorants to cosmetics to skin care; Grooming which includes blades razors and electronic hair removal devices such as electric razors and epilators; Health Care which includes oral care and personal health care products.; Fabric Care and Home Care which consists of a range of fabric care products home care products and batteries and Baby Feminine and Family Care which offers diapers pants baby wipe Bounty paper towel and Charmin toilet paper brands. The Company’s products are sold in over 180 countries and territories. P&G’s customers include mass merchandisers grocery stores membership club stores drug stores department stores salons distributors e-commerce and stores.

Leave a Reply

Procter & Gamble Co - Is it time to Sell?

Top Brokerage Firms are advising their investors on Procter & Gamble Co. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.